Lability of serum low-density lipoprotein cholesterol levels during screening in subgroup of Air Force/Texas Coronary Atherosclerosis Prevention Study (AFCAPS/TexCAPS) cohort

Journal of the American Osteopathic Association

Volumn 102, Issue 7, 2002, Pages 377-384

  Clearfield, Michael B ^a,b   Weis, Stephen E ^a   Willis, John M ^a   Vasenius, Keith Allen ^a   Mcconathy, Walter J ^a  

^a University of North Texas Health Science Center   (United States)

^b UNIVERSITY OF NORTH TEXAS   (United States)

Author keywords

AFCAPS TexCAPS; American Heart Association AHA step 1 diet; Cholesterol; Coronary heart disease; Labile LDL C

Indexed keywords

CHOLESTEROL; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; LIPID; LOW DENSITY LIPOPROTEIN CHOLESTEROL; TRIACYLGLYCEROL;

ADULT; AGED; AIR FORCE; ARTICLE; CHOLESTEROL BLOOD LEVEL; CONTROLLED STUDY; CORONARY ARTERY ATHEROSCLEROSIS; DIETARY INTAKE; DISEASE ASSOCIATION; FAMILIAL DISEASE; FEMALE; HEART DISEASE; HUMAN; INCIDENCE; LIPID ANALYSIS; LIPID BLOOD LEVEL; LIPOPROTEIN BLOOD LEVEL; MAJOR CLINICAL STUDY; MALE; MORBIDITY; MORTALITY; SCREENING; TRIACYLGLYCEROL BLOOD LEVEL;

AGED; CHOLESTEROL; CHOLESTEROL, HDL; CHOLESTEROL, LDL; CORONARY DISEASE; FEMALE; HUMANS; MALE; MIDDLE AGED; NUCLEAR FAMILY; PRIMARY PREVENTION; RANDOMIZED CONTROLLED TRIALS; SEX FACTORS; TRIGLYCERIDES;

EID: 0036078052     PISSN: 00986151     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (32)

1. Primary prevention of acute coronary events with lovastatin in men and women with average cholesterol levels: Results of AFCAPS/TexCAPS. Air Force/Texas Coronary Atherosclerosis Prevention Study
2. Design & rationale of the Air Force/Texas Coronary Atherosclerosis Prevention Study (AFCAPS/TexCAPS)
3. Intra-individual variation of serum cholesterol, triglycerides and high density lipoprotein cholesterol in normal humans
4. Intraindividual variability of plasma cholesterol and triglycerides and the effect of propranolol treatment
5. Importance of time interval between repeated measurements of total or high-density lipoprotein cholesterol when estimating an individual's baseline concentrations
6. Effect of time between measurements on within-subject variability for total cholesterol and high-density lipoprotein cholesterol in women
7. Variation in concentration of lipids, lipoprotein lipids, and apolipoproteins A-I and B in plasma from healthy women
8. Effect of recent food on estimation of high-density lipoprotein and total cholesterol in normal subjects
9. Individual variation in serum cholesterol levels
10. Serum cholesterol variations in individual patients
11. Within-person fluctuations of serum cholesterol and lipoproteins
12. Estimating an individual's true cholesterol level and response to intervention
13. Day-to-day variability of serum cholesterol, triglyceride, and high-density lipoprotein cholesterol levels. Impact on the assessment of risk according to the National Cholesterol Education Program guidelines
14. Variations in serum lipids and lipoproteins throughout the menstrual cycle
15. The effect of ascorbic acid on the seasonal variations in serum cholesterol levels
16. Blood lipid measurements
17. Dehydration during fasting increases serum lipids and lipoproteins
18. Variability of plasma lipids in response to emotional arousal
19. Diurnal variation of LDL and HDL cholesterol
20. Fluctuations of lipid and lipoprotein levels in hyperlipidemic postmenopausal women receiving hormone replacement therapy
21. Lipid level in the blood, based on multiple study data, and the characteristics of the course of ischemic heart disease
22. Apolipoprotein E isoform phenotype and LDL subclass response to a reduced-fat diet
23. Low-density lipoprotein subclass patterns and lipoprotein response to a reduced-fat diet in men
24. Plasma lipid distributions in selected North American populations: The Lipid Research Clinics Program Prevalence Study
25. Lipoprotein-cholesterol distributions in selected North American populations: The Lipid Research Clinics Program Prevalence Study
26. Atherogenic lipoprotein phenotype, a proposed marker for coronary heart disease risk
27. Defects of lipoprotein metabolism in familial combined hyperlipidaemia
28. Role of 3-hydroxy-3-methylglutaryl coenzyme A reductase inhibitors ("statins") in familial combined hyperlipidemia
29. A single cholesterol measurement underestimates the risk of coronary heart disease
30. Repeat measurement of case-control data: Correcting risk estimates for misclassification due to regression dilution of lipids in transient ischemic attacks and minor ischemic strokes
31. Systematic underestimation of association between serum cholesterol concentration and ischaemic heart disease in observational studies: Data from the BUPA study